Back To Top
Product R&D
The class 1 new durg X842 that used to treat gastroesophageal reflux disease

The SND001 class 1 new drug X842 potassium competitive acid blocker(P-CABs) is...

Sentinel Lymph Node T cell(SLN-T) vaccine

The SND002 Sentinel Lymph Node T cell(SLN-T) vaccine has been approved to start the EU phase II clinical trial, and was included...

Oncolytic virus

SND005 oncolytic virus is a virus that preferently infects and kills tumor cells. Initially...

Learn more
Enterprise calendar
J.P. Morgan Healthcare Conference

January 13-16, 2020

New Drug Founders Club 2020 New Year Party

December 15,2019

3rd CEIBS-CCTMIS Translational Medicine Industry Forum

December 12,2019


December 4-6,2019